These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
916 related articles for article (PubMed ID: 25452040)
1. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects. Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040 [TBL] [Abstract][Full Text] [Related]
2. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease. Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809 [TBL] [Abstract][Full Text] [Related]
5. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy. Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826 [TBL] [Abstract][Full Text] [Related]
6. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
7. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals. Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832 [TBL] [Abstract][Full Text] [Related]
8. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection. Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552 [TBL] [Abstract][Full Text] [Related]
9. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study. Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals. Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189 [TBL] [Abstract][Full Text] [Related]
11. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production. Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147 [TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Chen DY; Shen GH; Chen YM; Chen HH; Lin CC; Hsieh CW; Lan JL Int J Tuberc Lung Dis; 2011 Feb; 15(2):192-200. PubMed ID: 21219680 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100 [TBL] [Abstract][Full Text] [Related]
14. The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays. Clifford V; Zufferey C; Germano S; Ryan N; Leslie D; Street A; Denholm J; Tebruegge M; Curtis N Tuberculosis (Edinb); 2015 May; 95(3):343-9. PubMed ID: 25837441 [TBL] [Abstract][Full Text] [Related]
15. [The clinical application of quantiferon TB-2G: its usefulness and limitations]. Sato S; Nagai H Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654 [TBL] [Abstract][Full Text] [Related]
16. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis? Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090 [TBL] [Abstract][Full Text] [Related]
17. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785 [TBL] [Abstract][Full Text] [Related]
18. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients. Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay]. Harada N Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047 [TBL] [Abstract][Full Text] [Related]
20. Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children. Hur YG; Crampin AC; Chisambo C; Kanyika J; Houben R; Ndhlovu R; Mzembe T; Lalor MK; Saul J; Branson K; Stanley C; Ngwira B; French N; Ottenhoff TH; Dockrell HM; Gorak-Stolinska P Clin Vaccine Immunol; 2014 Feb; 21(2):133-42. PubMed ID: 24285818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]